Go to public sitemap
HONEUR Meeting
This Q&A has been prepared to answer questions about HONEUR and related topics.
Real World Data and Real World Evidence – What’s the difference? Real World Data (RWD) is health data, usually created by healthcare professionals and also by patients, as part of routine health...
HONEUR’s principles Do you want to know more about HONEUR’s network principles? Check it out here.
RWE in practice Sweden – Since 1998, Sweden's national Cataract Registry has collected nationwide data on postoperative endophthalmitis (PE), which, although rare, results in blindness in between...
Our Mission To create a secure, collaborative platform that enables participants across Europe to liberate the transformational potential of Real World Data. Our Vision We want to help create a...
Join the network To join the HONEUR network, only few prerequisites are needed. Basically, any registry, hospital, physician association or any scientific institute with a dataset on patients with...
What is HONEUR? HONEUR stands for Haematology Outcomes Network in Europe. Historically, the network of data centres across Europe has often been duplicative and uncoordinated, so the...
Real World Data is critically important RWD is very different from data gathered in clinical trials. In clinical trials, strict basic conditions are applied to allow for the best comparability...
No Content
Cookie Consent Settings
Not found the answer you are looking for? Please contact Lars Halvorsen and / or Peter Moorthamer for all your HONEUR related technical questions.
Terms of Use
COVID-19 Update
27/08/2018 We are pleased to announce that the first site was contracted to the HONEUR network: Leicester Royal Infirmary is represented by Dr Mamta Garg, who is actively involved in research and...
27/09/2018 Our abstract “HONEUR (Haematology Outcomes Network in Europe) – A Federated Model to support Real World Data Research in Haematology” has been accepted at the Congress of the American...
05/10/2018 We are pleased to announce that we have signed the accession agreement to project HONEUR with Prof. Hajek from the Registry of Monoclonal Gammopathies (RMG) in the Czech Republic. The...
12/04/2019 Improving results for patients by realising the transformational potential of Real World Data BEERSE, BELGIUM, 11 April 2019 - The Janssen Pharmaceutical Companies of Johnson & Johnson...
This site is published by Janssen Pharmaceutica N.V., which is solely responsible for its content. This site is intended for the use of our visitors in Europe, the Middle East and Africa. Last...